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Background: Dextran sodium sulfate (DSS) is commonly used in mouse studies to induce a very reproducible
colitis that effectively mimics the clinical and histological features of human inflammatory bowel disease (IBD)
patients, especially ulcerative colitis. However, the mechanisms of action of DSS remain poorly understood, and
observations by our laboratory and other groups indicate that DSS contamination of colonic tissues from DSS-
treated mice potently inhibits the quantitative reverse-transcription polymerase chain reaction (qRT-PCR)
amplification of mRNA.
Results: A prior study used poly-A-mediated mRNA purification to remove DSS from RNA extracts, but we herein
report a second efficient and cost-effective approach to counteract this inhibition, using lithium chloride
precipitation to entirely remove DSS from RNAs. We also explored how DSS interferes with qRT-PCR process, and
we report for the first time that DSS can alter the binding of reverse transcriptase to previously primed RNA and
specifically inhibits the enzymatic activities of reverse transcriptase and Taq polymerase in vitro. This likely explains
why DSS-treated colonic RNA is not suitable to qRT-PCR amplification without a previous purification step.
Conclusion: In summary, we provide a simple method to remove DSS from colonic RNAs, and we demonstrate for
the first time that DSS can inhibit the activities of both polymerase and reverse transcriptase. In order to reliably
analyze gene expression in the colonic mucosa of DSS-treated mice, the efficiency rate of qRT-PCR must be the
same between all the different experimental groups, including the water-treated control group, suggesting that
whatever the duration and the percentage of the DSS treatment, RNAs must be purified.
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Dextran sodium sulfate (DSS), a sulfated polysaccharide,
is commonly used to induce colitis in rodents [1,2]. Ori-
ginally reported in 1985 by Ohkusa et al. who used DSS
to induce colitis in hamsters [3], the DSS model was
thereafter extrapolated to mice [4]. This chemical com-
pound is now extensively used by investigators studying
pathogenesis of colitis and factors affecting colitis. The
main interest of DSS-induced experimental colitis is that* Correspondence: eviennois@gsu.edu
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reproduction in any medium, provided the orthe model can mimic the clinical and histological features
of human inflammatory bowel disease (IBD), with ulcera-
tive colitis (UC) characteristics [5]. Moreover, DSS-based
studies using various therapeutic agents for human IBD
show that DSS-induced colitis can be used as a relevant
model for the translation of mouse induced colitis to
human disease [6].
Colitis is induced by the addition of DSS to drinking
water. Depending on the concentration, duration, and
frequency of DSS administration, the animals may develop
acute colitis, chronic colitis, or even colitis-induced
dysplastic lesions when combined with azoxymethane
(AOM) treatment [7-9]. When mice are given drinkingl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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appear on day 3 and are maximally expressed by day 7
[10]. Laroui et al. [11] suggested that the DSS associates
with medium-chain length fatty acids (MCFAs), such as
dodecanoate, in the colonic lumen. There, the colonic epi-
thelium absorbs and partially metabolizes MCFAs, poten-
tially explaining how the DSS enters epithelial cells [11].
In addition to being extensively used to induce intestinal
inflammation in wild-type (WT) mice, this method also
potently disturbs the mucosal barrier of mice that are gen-
etically susceptible to develop colitis (DSS could induce
and/or exacerbate the colitis) [12,13]. Therefore we can
approximate that one third of the researchers studying
colitis in mice are using the DSS model, hence the im-
portance of overcoming the pitfalls linked to this model.
Although the DSS model has been fully exploited for
20 years, the underlying mechanisms of DSS-induced
colitis are not yet entirely understood.
In our laboratory, we observed that the contamination
by DSS of colonic tissue inhibits quantitative reverse-
transcription polymerase chain reaction (q-RT-PCR)
amplification. This inhibitory effect of DSS was observed
in a dose-dependent manner, as previously described by
Kerr et al. [14], who suggested a poly-A-purification-
based technique to remove DSS from RNA extracts. We
developed another efficient and low-cost technique that
uses lithium chloride to entirely remove DSS from the
RNAs after their extraction from colonic tissue. This
technique has been extensively used in our laboratory
and by others [15-18], but has never been reported in
detail. Here, we describe the mechanisms underlying
DSS-mediated inhibition of q-RT-PCR and we provide a
detailed description of this lithium chloride-based RNAs
purification method.
Results and discussion
In vivo DSS exposure completely inhibits the qPCR
process without altering RNA integrity
To test whether in vivo DSS exposure can alter RNA integ-
rity, WT mice were exposed to drinking water containing
3% DSS for 7 days. RNAs from colon tissues of control
(water-treated) and DSS-treated mice were extracted
using the TRIzol reagent and resolved by electrophoresis.
RNA samples from control and DSS-treated colons
showed perfect integrity (Figure 1A), indicating that DSS
treatment does not alter RNAs synthesis and/or stability.
Next, cDNA synthesis and qPCR were performed on total
RNA from control and DSS-treated colons. Agarose gel
electrophoresis revealed that housekeeping gene 36B4
amplification products were obtained from control sam-
ples but not from DSS-treated samples (Figure 1B), dem-
onstrating that the in vivo exposure of colonic tissue to
DSS result in a complete inhibition of qPCR process. We
speculated that this could arise via inhibition of cDNAsynthesis and/or general inhibition of the qPCR process
itself.
Purification of RNAs using lithium chloride abolish the
inhibitory effect of DSS on qPCR
To remove all polysaccharides (including DSS) from the
samples, we purified the RNA using our lithium chloride
protocol (for details, see Methods). Briefly, the RNA
were precipitated twice by 0.1 volume of 8 M LiCl,
followed by a precipitation step in 0.1 volume of 3 M so-
dium acetate (pH 5.2) and 2 volumes of 100% ethanol.
The RNA were then centrifuged, pellets were washed
with 100 μL of 70% ethanol and RNAs were finally
dissolved in 20-50 μl of RNase-free water. After this
purification step, 36B4 amplification products were
observed from both DSS-treated and control samples
(Figure 1C), indicating that this simple purification
protocol is a very powerful tool to remove DSS from
RNA samples and counteract the previously observed in-
hibition of qPCR process. These data also confirm that
the cDNA synthesis and/or qPCR reactions cannot
occur properly in the presence of DSS. To exclude the
possibility that DSS directly binds to RNA, we per-
formed surface plasmon resonance (SPR) experiments
with increasing concentrations of DSS. RNAs were
coupled to the gold sensor surface of the chip, and in-
creasing concentrations of DSS were flowed over the
RNA-coupled chip surface. Our results indicated that
DSS molecule does not bind to RNA (Additional file 1).
Inhibition of the qPCR process does not occur with
individual components of DSS
In vitro experiments were used to examine the mechan-
ism by which the DSS inhibits qPCR amplification.
Colonic RNA from water-treated mice were treated
in vitro with increasing concentrations of DSS, and then
subjected to cDNA synthesis and qPCR. Treatment with
low concentrations of DSS (0.01 to 0.5 g/L) did not sig-
nificantly alter 36B4 amplification, whereas concen-
trations of DSS over 0.5 g/L completely inhibit 36B4
amplification (Figure 2A). Since DSS is composed of
successive glucose units substituted with sulfur groups,
we next investigated the effect of each DSS component
(dextran, glucose, and sodium sulfate) at concentrations
based on those of the DSS solution. In one polymer
chain of DSS, 138 glycosyl residues were present.
Equivalent concentrations for DSS associated molecules
have been calculated considering the equivalent number
of glucose or sulfate motifs, according to Laroui et al.
[11]. Our results revealed that increasing concentrations
of dextran, glucose, or sodium sulfate do not alter the
amplification of 36B4 (Figure 2B), indicating that the
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Figure 1 In vivo DSS exposure completely inhibits qPCR but does not alter RNA integrity. A) Total RNA was extracted from colonic tissues
obtained from mice treated with or without 3% DSS, and RNA integrity was assessed by 2% agarose gel electrophoresis. DSS treatment does not
alter the integrity of the RNA. B) After cDNA synthesis, qPCR was performed for the 36B4 amplicon. The amplification of 36B4 was totally inhibited in
DSS-treated mice. C) The DSS- and non-DSS RNA samples were purified using our lithium chloride protocol, and qPCR was performed. After lithium
chloride purification, 36B4 was successfully amplified from both DSS- and non-DSS samples.
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To test whether DSS inhibits Taq polymerase activity,
we synthesized cDNA from total RNA obtained from
non-DSS-exposed colonic tissue, incubated it with in-
creasing concentrations of DSS after the reverse tran-
scription step, and subject them to PCR amplification.
Our results revealed that DSS strongly inhibited PCR
amplification at concentrations over 0.01 g/L. (Figure 3A).
To test if this reflect inhibition of the Taq polymerase
itself, we incubated a constant quantity of Taq polymer-
ase with different concentrations of DSS, and used an
enzyme assay kit to perform fluorescence-based quanti-
fication of polymerase activity. Results revealed that
DSS dose-dependently decreased the polymerase activ-
ity (Figure 3B). In contrast, the polymerase activity was
not altered in the presence of dextran alone (a compo-
nent of DSS). These findings demonstrate that DSS spe-
cifically and dose-dependently inhibits Taq polymerase
activity.DSS inhibits the activity of the reverse transcriptase
To assess whether DSS also inhibits the reverse tran-
scriptase activity, we incubated a constant amount of
reverse transcriptase (0.4 U) with DSS or water and
assessed reverse transcriptase activity using an enzyme
assay kit. Results indicate that the reverse transcriptase
activity is drastically decreased in the presence of 5.10-4
or 5.10-5 g/L of DSS, compared to water control (Figure 4).
Thus, DSS appears to block the RT-qPCR process
by inhibiting both Taq polymerase and reverse tran-
scriptase.
DSS alters the interaction between primed RNAs and
reverse transcriptase
To examine the mechanism by which the DSS alters re-
verse transcriptase activity, we used SPR to analyze
whether DSS modifies the interaction between reverse
transcriptase and primed RNA. Two successive injec-
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Figure 2 In vitro RNA exposure to DSS, but not DSS-associated molecules, completely inhibits qPCR. A) Total RNA from non-DSS samples
was incubated in vitro with different concentrations of DSS, and the qPCR amplification of 36B4 was assessed. The amplification of 36B4 was
blocked by 1 or 5 g/L of DSS. Abbreviations: ***, p < 0.001; nd, not detected. B) Total RNA from non-DSS samples was incubated in vitro with
different concentrations of DSS or its components (dextran, glucose and sodium sulfate), and the qPCR amplification of 36B4 was assessed. The
amplification of 36B4 was fully blocked by DSS, but the component compounds did not alter the amplification of 36B4 at any tested concentration.
Abbreviation: **, p < 0.01; ***, p < 0.001; nd, not detected.
Viennois et al. BMC Research Notes 2013, 6:360 Page 4 of 8
http://www.biomedcentral.com/1756-0500/6/360were performed to load the enzyme on the chip. A
quantity of 830 ng of RNA that had been pre-primed
with random primers was injected twice as the analyte.
We found that after two injections, the primed RNA
directly bound to the reverse transcriptase, deflecting
the resonance angle to 42 mDeg (Figure 5A). The ex-
periment was then repeated with primed RNA that had
been pre-incubated with different concentrations of
DSS (0.05, 0.5 and 5 g/L). Interestingly, the presence of
DSS decreased the binding of primed RNA to the
reverse transcriptase by 1.6 fold and deflected the reson-
ance angle to 25.6 mDeg, regardless of the concentra-
tion (Figure 5B-D).The injection of various concentrations of DSS alone
did not deflect the resonance angle, demonstrating that
DSS alone did not directly bind to the purified reverse
transcriptase (data not shown). Taken together, these
results indicate that DSS alters the binding between
reverse transcriptase and primed RNA, partly explaining
the inhibitory effect of DSS on reverse transcriptase
activity.
Conclusion
DSS is widely used to induce experimental colitis. Our
lab and others have found that DSS contamination of
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Figure 3 DSS inhibits the activity of Taq polymerase. A) RNA
from non-DSS-treated tissue was reverse transcribed, the cDNA was
incubated in vitro with DSS, and the amplification of 36B4 was
assessed by qPCR. Incubation with 0.01 g/L DSS triggered a small
but significant decrease in the amplification of 36B4, and 0.05 g/L
and higher concentrations of DSS fully inhibited the amplification of
36B4 by qPCR. Abbreviations: ns, non-significant; nd, not detected;
***, p < 0.001. B) Constant amounts of Taq polymerase (10 mU) were
incubated with water or increasing concentration of DSS, and
polymerase activity was assessed. DSS dose-dependently decreased





























Figure 4 DSS inhibits the activity of the reverse transcriptase.
Constant amounts of M-MuLV reverse transcriptase (0.4 U) were
incubated with water or DSS, and reverse transcriptase activity was
assessed. DSS decreased the activity of the reverse transcriptase.
Abbreviations: **, p < 0.01; ***, p < 0.001; ns, non-significant.
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in DSS-exposed tissues requires removal of the contam-
inating DSS. To address this, we developed an efficient
and low-cost lithium chloride-based technique to en-
tirely remove DSS from RNAs. In this article, we providea simple protocol based on lithium chloride purification
(for details, see Methods) that will allow researchers to
analyze the effect of DSS-induced colitis on gene expres-
sion levels.
We also report here in vitro experiments investigating
the mechanism by which DSS inhibits qPCR. Our results
revealed that DSS does not bind to RNA or alter its in-
tegrity, but rather inhibits the activity of both reverse
transcriptase and DNA-dependent Taq polymerase. This
inhibition is specific to DSS, as its component molecules
(glucose, dextran and sodium sulfate) did not inhibit
RT-qPCR. In addition, we found that the inhibitory ef-
fect of DSS on reverse transcriptase activity is at least
partially due to its ability to alter the binding between
RNAs and the reverse transcriptase.
DSS has been shown to interact with various cellular
and bacterial components, thereby altering certain bio-
logical mechanisms. For example, DSS could competes
with poly(U) [19] and inhibits ribonuclease activity [20,21].
Other natural and synthetic polyanionic polymers have
been found to play important roles in the association of
mRNA with ribosomes, and thus in mRNA translation
[19]. Together with our data, these reports suggest that
DSS can interact with cell components and alter the
replication process.
Based on observations that DSS can inhibit qPCR, we
herein sought to elucidate the underlying mechanism.
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Figure 5 DSS alters the interaction between primed RNA and reverse transcriptase. Primed RNA was incubated with or without different
concentrations of DSS, and binding to the M-MuLV reverse transcriptase was determined by SPR (measured in mDeg). A) The primed RNA binds
to the reverse transcriptase, deflecting the resonance angle to 42 mDeg. B-D) After incubation with 0.05 (B), 0.5 (C) or 5 (D) g/L of DSS, the
primed RNA binds to the reverse transcriptase, deflecting the resonance angle to 25.6 mDeg. Δt = Δtotal.
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crease our understanding of how DSS may act in vivo
and suggest that further studies are warranted to exam-
ine the impact of this commonly used experimental re-




All studies were performed in accordance with the Institu-
tional Animal Care and Use Committee at Georgia State
University (Atlanta, GA). All procedures were approved
and are registered in the protocol IACUC ID: A11025, ap-
proval date 8/30/2011 to 8/30/2014. Strains, ages, and the
number of animals follow the established protocol.
The DSS treatment on mice were carried out in
C57BL/6 mice (8 wk, 18–22 g) obtained from Jackson
Laboratories (Bar Harbor, ME). Mice were group housed
under a controlled temperature (25°C) and photoperiod(12:12-h light–dark cycle) and allowed unrestricted access
to standard mouse chow and tap water. DSS [40,000 Da,
3% (wt/vol), ICN Biochemicals, Aurora, OH] was diluted
at 3% in drinking water. After 7 days under DSS treat-
ment, the mice were sacrificed by CO2 euthanasia. A
small piece (50 mg) of proximal colon was taken for
RNA extraction.
RNA extraction
Total RNA was isolated from colonic tissues using TRIzol
(Life Technologies, Carlsbad, CA) according to the manu-
facturer’s instructions. Where indicated, RNA was purified
via precipitation with lithium chloride. The RNA integrity
was assessed by 2% agarose gel electrophoresis.
Lithium chloride purification
In order to be purified from all polysaccharides including
DSS, a purification using lithium chloride was performed.
The RNA were incubated with 0.1 volume of 8 M LiCl
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centrifuged at 14,000 g for 30 min at 4°C. The superna-
tants were poured out and the pellets of RNA dissolved in
200 μl of RNase-free water. The 2-hour incubation with
lithium chloride, the centrifugation and the pellet suspen-
sions were repeated once more. The RNA was precipi-
tated at −20°C for 30 min, in 0.1 volume of 3 M sodium
acetate (pH 5.2) and 2 volumes of 100% absolute ethanol.
The RNA was then centrifuged at 14,000 g for 30 min at
4°C. The supernatants were poured out and the pellets
were washed with 100 μL of 70% ethanol and centrifuged
at 14,000 g for 10 min at 4°C. The supernatants were re-
moved and the RNA was dissolved in 20–50 μl of RNAse-
free water.
cDNA synthesis and qPCR
cDNA were synthesized using the Maxima First-Strand
cDNA Synthesis Kit (Thermo Scientific, Waltham, MA)
according to the manufacturer’s instructions. Expression
of the total RNA was quantified by qPCR using Maxima
SYBR Green/ROX qPCR Master Mix (Thermo Scientific)
in a Realplex Thermal Cycler (Eppendorf, Hauppauge,
NY). The qPCR primer sequences for 36B4 were 36B4-F:
TCCAGGCTTTGGGCATCA and 36B4-R: CTTTATCA
GCTGCACATCACTCAGA.
Polymerase assay
The polymerase enzymatic activity was measured using
the EvaEZ™ Fluorometric Polymerase Activity Assay kit
(Biotium, Hayward, CA) according to the manufacturer’s
instructions. Briefly, 0.01 units (10 mU) of recombinant
Taq DNA polymerase (Thermo Scientific) were incu-
bated with water or DSS (0.01 to 1 g/L). Dextran was
used as a control. The enzymatic activity was quantified
by fluorescence using the Realplex Thermal Cycler
(Eppendorf). The fluorescence was read every 1 min for
60 min during the elongation step at 72°C.
Reverse transcriptase assay
The reverse transcriptase enzymatic activity was mea-
sured using the EnzChek Reverse Transcriptase Assay
kit (Life Technologies, Carlsbad, CA) according to the
manufacturer’s instructions. Briefly, 0.4 units of the re-
verse transcriptase, M-MuLV RT (Thermo Scientific)
were incubated at 25°C with water or DSS (0.00005 g/L
or 0.0005 g/L) in presence of a standardized polyA RNA
template, oligodT and polymerization buffer. The en-
zymatic activity was quantified by fluorescence using a
Synergy 2 Multi-Mode Microplate Reader (Biotek).
Surface plasmon resonance (SPR)
For SPR experiments, gold sensor chips were used
(Biosensing Instrument, Tempe, AZ, USA). Briefly, the
principle of this technique is the following: A firstmolecule is coupled to the gold sensor surface. The solu-
tion containing the second molecule (the analyte) then
is flowed over the surface. This creates a mass change
on the sensor surface as the two molecules interact,
which is detected in real time as a deflection of the res-
onance angle in mDeg. In that specific experiment, the
gold chip was cleaned and treated as previously de-
scribed [22-24]. After placing a chip into the BI-2000
SPR (Biosensing Instrument) machine each gold biosen-
sor chip covered with carboxydextran was activated
using a mixture of 1-ethyl-3-(3-dimethylaminopropyl)
carbodiimide/N-hydroxysuccinimide (EDC/NHS) to form
amide linkages between purified protein and the chip-
bound carboxydextran. Two successive injections of
2,400 units of M-MuLV Reverse Transcriptase (thermo
Scientific) each were performed. The reverse transcriptase
was previously purified using Slide-A-Lyser® Mini dialysis
devices (ThermoScientific) and suspended in PBS. After
coating the chip with reverse transcriptase, RNA, previ-
ously primed using random primers (Thermo Scientific)
incubated at 42°C, or primed RNA incubated with DSS in
different concentrations (0.05, 0.5, 5 g/L) were passed over
the chip twice. A two-step interaction curve was obtained.
The first step involved adsorption of primed RNA to the
maximal level. In the second step, when the flow of
primed RNA concentration returned to zero, nonspecific
adsorbed primed RNA were released with the running
buffer. The deviation of the resonance angle thus de-
creased to a plateau located at a level above the initial
baseline. We assessed the laser deflection as directly cor-
related to the binding level. We thus used the laser devi-
ation angle as the optimal parameter for the binding
affinity. All comparisons between the different solutions
of primed RNA and primed RNA with different concen-
trations of DSS were performed as a measure of the laser
deviation in mDegrees (mDeg).
Statistical analysis
Values were expressed as means ± standard error of
mean (SEM). Statistical analysis was performed using an
unpaired two-tailed t-test by GraphPad Prism 5 software.
p <0.05 was considered statistically significant.
Availability of supporting data
The data sets supporting the results of this article are in-
cluded within the article and its additional file.Additional file
Additional file 1: RNAs were coated to the gold chip. The binding of
DSS to the RNA was determined by SPR (measured in mDeg). Increasing
concentrations of DSS (0.2, 0.3, 0.4, 0.5 and 1 g/L) were passed over the
chip. No deflection of the laser angle was observed meaning the DSS
does not bind to the RNA.
Viennois et al. BMC Research Notes 2013, 6:360 Page 8 of 8
http://www.biomedcentral.com/1756-0500/6/360Abbreviations
AOM: Azoxymethane; CD: Crohn’s disease; DSS: Dextran sodium sulfate;
IBD: Inflammatory bowel disease; LiCl: Lithium chloride; SPR: Surface plasmon
resonance; UC: Ulcerative colitis.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
EV and DM conceived and designed the experiments, analyzed the data, and
wrote the manuscript. EV performed the experiments. MTB edited the
manuscript. FC contributed reagents and materials. HL provided input into
the project’s direction. All authors read and approved the final manuscript.
Acknowledgements
This work was supported by grants from the Department of Veterans Affairs
and the National Institutes of Health National Instituteof Diabetes and
Digestive and Kidney Diseases by the grant R01-DK-071594 (to D.M). We
dedicate this article to the memory of Dr. Shanthi V. Sitaraman, a brilliant
scientist, dedicated physician, passionate humanitarian and dearest friend.
Author details
1Department of Biology, Center for Diagnostics and Therapeutics, Georgia
State University, Atlanta GA 30303, USA. 2Department of Gastroenterology,
Shanghai Fifth People’s Hospital, Fudan University, 128 Ruili Road, 200240,
Shanghai, People’s Republic of China. 3Veterans Affairs Medical Center,
Decatur GA 30033, USA.
Received: 31 January 2013 Accepted: 3 September 2013
Published: 8 September 2013
References
1. Dieleman LA, Palmen MJ, Akol H, Bloemena E, Pena AS, Meuwissen SG, Van
Rees EP: Chronic experimental colitis induced by dextran sulphate
sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp
Immunol 1998, 114(3):385–391.
2. Elson CO, Sartor RB, Tennyson GS, Riddell RH: Experimental models of
inflammatory bowel disease. Gastroenterology 1995, 109(4):1344–1367.
3. Ohkusa T: Production of experimental ulcerative colitis in hamsters by
dextran sulfate sodium and changes in intestinal microflora. Nihon
Shokakibyo Gakkai Zasshi 1985, 82(5):1327–1336.
4. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R: A novel
method in the induction of reliable experimental acute and chronic
ulcerative colitis in mice. Gastroenterology 1990, 98(3):694–702.
5. Cooper HS, Murthy SNS, Shah RS, Sedergran DJ: Clinicopathological study
of dextran sulfate sodium experimental murine colitis. Lab Invest 1993,
69(2):238–249.
6. Melgar S, Karlsson L, Rehnstrom E, Karlsson A, Utkovic H, Jansson L,
Michaelsson E: Validation of murine dextran sulfate sodium-induced
colitis using four therapeutic agents for human inflammatory bowel
disease. Int Immunopharmacol 2008, 8(6):836–844.
7. De Robertis M, Massi E, Poeta ML, Carotti S, Morini S, Cecchetelli L, Signori E,
Fazio VM: The AOM/DSS murine model for the study of colon
carcinogenesis: from pathways to diagnosis and therapy studies.
J Carcinog 2011, 10:9.
8. Kanneganti M, Mino-Kenudson M, Mizoguchi E: Animal models of colitis-
associated carcinogenesis. J Biomed Biotechnol 2011, 2011:342637.
9. Perse M, Cerar A: Dextran sodium sulphate colitis mouse model: traps
and tricks. J Biomed Biotechnol 2012, 2012:718617.
10. Yan Y, Kolachala V, Dalmasso G, Nguyen H, Laroui H, Sitaraman SV, Merlin D:
Temporal and spatial analysis of clinical and molecular parameters in
dextran sodium sulfate induced colitis. PLoS One 2009, 4(6):e6073.
11. Laroui H, Ingersoll SA, Liu HC, Baker MT, Ayyadurai S, Charania MA, Laroui F,
Yan Y, Sitaraman SV, Merlin D: Dextran sodium sulfate (DSS) induces
colitis in mice by forming nano-lipocomplexes with medium-chain
-length fatty acids in the colon. PLoS One 2012, 7(3):e32084.
12. Wirtz S, Neufert C, Weigmann B, Neurath MF: Chemically induced mouse
models of intestinal inflammation. Nat Protoc 2007, 2(3):541–546.
13. Wirtz S, Neurath MF: Mouse models of inflammatory bowel disease.
Adv Drug Deliv Rev 2007, 59(11):1073–1083.14. Kerr TA, Ciorba MA, Matsumoto H, Davis VR, Luo J, Kennedy S, Xie Y, Shaker A,
Dieckgraefe BK, Davidson NO: Dextran sodium sulfate inhibition of real-time
polymerase chain reaction amplification: a poly-A purification solution.
Inflamm Bowel Dis 2012, 18(2):344–348.
15. Charania MA, Ayyadurai S, Ingersoll SA, Xiao B, Viennois E, Yan Y, Laroui H,
Sitaraman SV, Merlin D: Intestinal epithelial CD98 synthesis specifically
modulates expression of colonic microRNAs during colitis. Am J Physiol
Gastrointest Liver Physiol 2012, 302(11):G1282–1291.
16. Chassaing B, Srinivasan G, Delgado MA, Young AN, Gewirtz AT, Vijay-Kumar
M: Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive
biomarker for intestinal inflammation. PLoS One 2012, 7(9):e44328.
17. Dalmasso G, Nguyen HT, Ingersoll SA, Ayyadurai S, Laroui H, Charania MA,
Yan Y, Sitaraman SV, Merlin D: The PepT1-NOD2 signaling pathway
aggravates induced colitis in mice. Gastroenterology 2011, 141(4):1334–1345.
18. Nguyen HT, Dalmasso G, Torkvist L, Halfvarson J, Yan Y, Laroui H, Shmerling D,
Tallone T, D'Amato M, Sitaraman SV, et al: CD98 expression modulates
intestinal homeostasis, inflammation, and colitis-associated cancer in mice.
J Clin Invest 2011, 121(5):1733–1747.
19. Miyazawa F, Olijnyk OR, Tilley CJ, Tamaoki T: Interactions between dextran
sulfate and Escherichia coli ribosomes. Biochim Biophys Acta 1967,
145(1):96–104.
20. Fellig J, Wiley CE: The inhibition of pancreatic ribonuclease by anionic
polymers. Arch Biochem Biophys 1959, 85:313–316.
21. Philipson L, Zetterqvist O: The presence of DNA in human erythrocyte
membranes. Biochim Biophys Acta 1964, 91:171–173.
22. Charania MA, Laroui H, Liu H, Viennois E, Ayyadurai S, Xiao B, Ingersoll SA,
Kalman D, Merlin D: Intestinal epithelial CD98 directly modulates the
innate host response to enteric bacterial pathogens. Infect Immun 2013,
81(3):923–934.
23. Laroui H, Yan Y, Narui Y, Ingersoll SA, Ayyadurai S, Charania MA, Zhou F,
Wang B, Salaita K, Sitaraman SV, et al: L-Ala-gamma-D-Glu-meso-
diaminopimelic acid (DAP) interacts directly with leucine-rich region
domain of nucleotide-binding oligomerization domain 1, increasing
phosphorylation activity of receptor-interacting serine/threonine-protein
kinase 2 and its interaction with nucleotide-binding oligomerization
domain 1. J Biol Chem 2011, 286(35):31003–31013.
24. Yao X, Li X, Toledo F, Zurita-Lopez C, Gutova M, Momand J, Zhou F:
Sub-attomole oligonucleotide and p53 cDNA determinations via a
high-resolution surface plasmon resonance combined with
oligonucleotide-capped gold nanoparticle signal amplification.
Anal Biochem 2006, 354(2):220–228.
doi:10.1186/1756-0500-6-360
Cite this article as: Viennois et al.: Dextran sodium sulfate inhibits the
activities of both polymerase and reverse transcriptase: lithium chloride
purification, a rapid and efficient technique to purify RNA. BMC Research
Notes 2013 6:360.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
